Effects of adenosine A1 and A2A receptor activation on the evoked release of glutamate from rat cerebrocortical synaptosomes

被引:78
作者
Marchi, M
Raiteri, L
Risso, F
Vallarino, A
Bonfanti, A
Monopoli, A
Ongini, E
Raiteri, M
机构
[1] Univ Genoa, Dipartimento Med Sperimentale, Sez Farmacol & Tossicol, I-16148 Genoa, Italy
[2] Nicox Res Inst, Milan, Italy
[3] Ctr Eccellenza Cell Cell Commun, Genoa, Italy
关键词
adenosine; A(1) receptors; A(2A) receptors; glutamate release; cerebral cortex; SCH58261; ischaemia;
D O I
10.1038/sj.bjp.0704712
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of adenosine A(2A) and A(1) receptor activation on the release of glutamate were studied in rat cerebral cortex synaptosomes exposed in superfusion to adenosine receptor ligands. 2 Adenosine (0.1 muM) produced a significant potentiation of the Ca2+-dependent K+(15 mm)evoked [H-3]-D-aspartate overflow (20.4+/-3.5%), which was blocked by A(2A) blocker SCH58261 (0.1 muM). At higher concentrations (10-1000 muM) adenosine inhibited in a DPCPX-sensitive manner the Ca2+-dependent K+-evoked [H-3]-D-aspartate overflow. The inhibitory effect of adenosine at 1000 muM was significantly increased by SCH58261. This inhibition was antagonized by 1 muM DPCPX. Adenosine did not produce any effect on basal release. 3 The A(2A) receptor agonist CGS 21680 was ineffective on basal release, but stimulated the Ca2+-dependent K+-evoked overflow of [H-3]-D-aspartate (EC50 similar or equal to 1 pM). The effect of 0.01 nM CGS 21680 was totally sensitive to the A(2A) receptor antagonist SCH58261 (IC50 similar or equal to 5 nM). 4 The A(1) receptor agonist CCPA inhibited the Ca2+-dependent K+-evoked [H-3]-D-aspartate overflow (EC50 similar or equal to 20 nM). The effect of 100 nM CCPA was abolished by 100 nM of the A(1) receptor antagonist DPCPX. 5 The K+(15 mM)-evoked overflow of endogenous glutamate was enhanced by CGS 21680 (0.01 nM) and inhibited by CCPA (0.1 muM). The effect of CGS 21680 was abolished by SCH58261 (0.1 muM) and that of CCPA by DPCPX (0.1 muM). 6 It is concluded that adenosine and adenosine receptor agonists modulate glutamate release by activating inhibitory A(1) and excitatory A(2A) receptors present on glutamatergic terminals of the rat cerebral cortex.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 36 条
[1]   Effects of repeated administration of selective adenosine A(1) and A(2A) receptor agonists on pentylenetetrazole-induced convulsions in the rat [J].
Adami, M ;
Bertorelli, R ;
Ferri, N ;
Foddi, MC ;
Ongini, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 294 (2-3) :383-389
[2]   Modulation of Ca2+ channels by activation of adenosine A(1) receptors in rat striatal glutamatergic nerve terminals [J].
Ambrosio, AF ;
Malva, JO ;
Carvalho, AP ;
Carvalho, CM .
NEUROSCIENCE LETTERS, 1996, 220 (03) :163-166
[3]  
BARRIE AP, 1993, J NEUROCHEM, V60, P1081
[4]   The effect of nucleotides and adenosine on stimulus-evoked glutamate release from rat brain cortical slices [J].
Bennett, GC ;
Boarder, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (03) :617-623
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
CASATI C, 1994, J PHARMACOL EXP THER, V268, P1506
[7]   The effective stagnant thermal conductivity of porous media with periodic structures [J].
Cheng, P ;
Hsu, CT .
JOURNAL OF POROUS MEDIA, 1999, 2 (01) :19-38
[8]   ADENOSINE DECREASES ASPARTATE AND GLUTAMATE RELEASE FROM RAT HIPPOCAMPAL SLICES [J].
CORRADETTI, R ;
CONTE, GL ;
MORONI, F ;
PASSANI, MB ;
PEPEU, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 104 (1-2) :19-26
[9]   PURINERGIC MODULATION OF THE EVOKED RELEASE OF [H-3]ACETYLCHOLINE FROM THE HIPPOCAMPUS AND CEREBRAL-CORTEX OF THE RAT - ROTE OF THE ECTONUCLEOTIDASES [J].
CUNHA, RA ;
RIBEIRO, JA ;
SEBASTIAO, AM .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1994, 6 (01) :33-42
[10]   Evidence for high affinity binding sites for the adenosine A(2A) receptor agonist [H-3] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A(2A) receptors [J].
Cunha, RA ;
Johansson, B ;
Constantino, MD ;
Sebastiao, AM ;
Fredholm, BB .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (03) :261-271